Chilton Capital Management LLC Acquires New Position in CME Group Inc. $CME

Chilton Capital Management LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 381 shares of the financial services provider’s stock, valued at approximately $105,000.

A number of other institutional investors also recently bought and sold shares of CME. GQG Partners LLC lifted its holdings in CME Group by 7,676.3% in the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after acquiring an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP raised its position in CME Group by 370.5% in the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after purchasing an additional 2,089,935 shares during the period. Nuveen LLC acquired a new position in shares of CME Group in the 1st quarter valued at $218,842,000. Alliancebernstein L.P. grew its holdings in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock worth $330,182,000 after purchasing an additional 808,740 shares during the period. Finally, Egerton Capital UK LLP grew its holdings in shares of CME Group by 79.4% during the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock worth $459,003,000 after purchasing an additional 765,773 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock worth $3,527,956 over the last 90 days. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms have commented on CME. Barclays decreased their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Friday. UBS Group lowered their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research report on Thursday. TD Cowen boosted their target price on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday. Finally, Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $284.53.

CME Group Price Performance

Shares of CME opened at $269.54 on Monday. The company has a market cap of $97.14 billion, a P/E ratio of 26.12, a PEG ratio of 6.65 and a beta of 0.41. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm’s 50 day moving average price is $266.47 and its 200 day moving average price is $271.90.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm posted $2.68 earnings per share. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. On average, research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is 48.45%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.